Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Benefit-Risk Reporting for FDA-Cleared Artificial Intelligence−Enabled Medical Devices
9
Zitationen
8
Autoren
2025
Jahr
Abstract
This cross-sectional study suggests that despite increasing clearance of AI/ML devices, standardized efficacy, safety, and risk assessment by the FDA are lacking. Dedicated regulatory pathways and postmarket surveillance of AI/ML safety events may address these challenges.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.339 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.211 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.614 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.478 Zit.